Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Mar 31, 2026
Sale
Shares
1,390
Price
$78.33
Total Value
$108.88K
Shares Held After
112,977
% of Holdings
1.2%

Processa Pharmaceuticals, Inc. (PCSA)

SKIBSTED RUSSELL — Chief Financial Officer
Mar 31, 2026
Purchase
Shares
2,324
Price
$2.54
Total Value
$5.89K
Shares Held After
2,324
% of Holdings
100.0%
Mar 31, 2026
Sale
Shares
599
Price
$80.11
Total Value
$47.99K
Shares Held After
0
% of Holdings
100.0%
Mar 31, 2026
Purchase
Shares
2,269
Price
$2.54
Total Value
$5.75K
Shares Held After
2,325
% of Holdings
97.6%

Processa Pharmaceuticals, Inc. (PCSA)

Bigora Sian — Chief Development Officer
Mar 31, 2026
Purchase
Shares
2,107
Price
$2.54
Total Value
$5.34K
Shares Held After
3,711
% of Holdings
56.8%

Polyrizon Ltd. (PLRZ)

Adler Oz — Director
Mar 31, 2026
Sale
Shares
3,292
Price
$12.05
Total Value
$39.67K
Shares Held After
19,850
% of Holdings
14.2%

Polyrizon Ltd. (PLRZ)

Carmel Liron — Director
Mar 31, 2026
Sale
Shares
942
Price
$12.36
Total Value
$11.64K
Shares Held After
3,127
% of Holdings
23.2%

Polyrizon Ltd. (PLRZ)

Izraeli Tomer — Director
Mar 31, 2026
Sale
Shares
500
Price
$11.85
Total Value
$5.92K
Shares Held After
31,512
% of Holdings
1.6%
Mar 31, 2026
Purchase
Shares
1,160,000
Price
$3.45
Total Value
$4.00M
Shares Held After
13,160,000
% of Holdings
8.8%
Mar 31, 2026
Purchase
Shares
150,000
Price
$20.00
Total Value
$3.00M
Shares Held After
2,359,025
% of Holdings
6.4%

SOPHiA GENETICS SA (SOPH)

Puylaert Kevin — Chief Sales Officer
Mar 31, 2026
Sale
Shares
3
Price
$4.71
Total Value
$14.13
Shares Held After
92,383
% of Holdings
0.0%
Mar 31, 2026
Purchase
Shares
5,000
Price
$12.62
Total Value
$63.10K
Shares Held After
20,001
% of Holdings
25.0%

CURIS INC (CRIS)

KAITIN KENNETH I — Director
Mar 31, 2026
Purchase
Shares
10,000
Price
$0.55
Total Value
$5.49K
Shares Held After
11,407
% of Holdings
87.7%
Mar 31, 2026
Purchase
Shares
15,000
Price
$2.04
Total Value
$30.60K
Shares Held After
21,246
% of Holdings
70.6%
Mar 31, 2026
Sale
Shares
7,000,000
Price
$34.66
Total Value
$242.62M
Shares Held After
5,503,418
% of Holdings
56.0%
Mar 31, 2026
Sale
Shares
29,985
Price
$4.38
Total Value
$131.48K
Shares Held After
1,430,423
% of Holdings
2.1%
Mar 31, 2026
Purchase
Shares
34,000
Price
$19.31
Total Value
$656.54K
Shares Held After
1,726,039
% of Holdings
2.0%
Mar 31, 2026
Sale
Shares
21,338
Price
$32.12
Total Value
$685.31K
Shares Held After
9,597
% of Holdings
69.0%
Mar 31, 2026
Sale
Shares
431
Price
$54.35
Total Value
$23.43K
Shares Held After
38,120
% of Holdings
1.1%
Mar 31, 2026
Sale
Shares
6,609
Price
$53.87
Total Value
$356.00K
Shares Held After
38,551
% of Holdings
14.6%
Mar 31, 2026
Sale
Shares
19,060
Price
$13.45
Total Value
$256.36K
Shares Held After
455,878
% of Holdings
4.0%

DAXOR CORP (DXR)

Michel Robert J — Chief Financial Officer
Mar 31, 2026
Purchase
Shares
1,000
Price
$9.90
Total Value
$9.90K
Shares Held After
21,050
% of Holdings
4.8%

Zenas BioPharma, Inc. (ZBIO)

Lu Hongbo — Director
Mar 31, 2026
Purchase
Shares
75,000
Price
$20.00
Total Value
$1.50M
Shares Held After
422,968
% of Holdings
17.7%

Clene Inc. (CLNN)

Ugwumba Chidozie — 10% Owner
Mar 31, 2026
Sale
Shares
67,991
Price
$4.88
Total Value
$331.80K
Shares Held After
431,094
% of Holdings
13.6%

CYTOKINETICS INC (CYTK)

Callos Andrew — EVP, Chief Commercial Officer
Mar 31, 2026
Sale
Shares
3,639
Price
$65.00
Total Value
$236.53K
Shares Held After
66,004
% of Holdings
5.2%

ANAPTYSBIO, INC (ANAB)

Schmid John P. — Director
Mar 30, 2026
Sale
Shares
522
Price
$57.40
Total Value
$29.96K
Shares Held After
31,622
% of Holdings
1.6%

ANAPTYSBIO, INC (ANAB)

Schmid John P. — Director
Mar 30, 2026
Sale
Shares
7,527
Price
$56.70
Total Value
$426.78K
Shares Held After
32,144
% of Holdings
19.0%

ANAPTYSBIO, INC (ANAB)

Schmid John P. — Director
Mar 30, 2026
Sale
Shares
12,596
Price
$55.71
Total Value
$701.71K
Shares Held After
39,671
% of Holdings
24.1%
Mar 30, 2026
Sale
Shares
25,000
Price
$22.37
Total Value
$559.23K
Shares Held After
986,667
% of Holdings
2.5%
Mar 30, 2026
Sale
Shares
10,834
Price
$5.54
Total Value
$60.04K
Shares Held After
89,166
% of Holdings
10.8%

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

Christianson Mark — Business Development Director
Mar 30, 2026
Sale
Shares
15,363
Price
$0.74
Total Value
$11.37K
Shares Held After
198,920
% of Holdings
7.2%
Mar 30, 2026
Sale
Shares
790
Price
$30.02
Total Value
$23.71K
Shares Held After
10,503
% of Holdings
7.0%
Mar 30, 2026
Sale
Shares
6,710
Price
$29.26
Total Value
$196.31K
Shares Held After
11,293
% of Holdings
37.3%

PRECISION OPTICS CORPORATION, INC. (POCI)

TRAUT JOSEPH — Chief Operating Officer
Mar 30, 2026
Purchase
Shares
41,666
Price
$3.60
Total Value
$150.00K
Shares Held After
41,666
% of Holdings
100.0%

PRECISION OPTICS CORPORATION, INC. (POCI)

COLL WAYNE M — Chief Financial Officer
Mar 30, 2026
Purchase
Shares
20,833
Price
$3.60
Total Value
$75.00K
Shares Held After
35,239
% of Holdings
59.1%
Mar 30, 2026
Purchase
Shares
1,388
Price
$3.60
Total Value
$5.00K
Shares Held After
143,959
% of Holdings
1.0%
Mar 30, 2026
Purchase
Shares
2,000
Price
$17.08
Total Value
$34.16K
Shares Held After
15,500
% of Holdings
12.9%

Nuvalent, Inc. (NUVL)

Noci Darlene — Chief Development Officer
Mar 30, 2026
Sale
Shares
2,968
Price
$98.13
Total Value
$291.25K
Shares Held After
58,117
% of Holdings
4.9%

Nuvalent, Inc. (NUVL)

Noci Darlene — Chief Development Officer
Mar 30, 2026
Sale
Shares
2,532
Price
$97.43
Total Value
$246.69K
Shares Held After
61,085
% of Holdings
4.0%

IRADIMED CORP (IRMD)

Susi Roger E. — Director
Mar 30, 2026
Sale
Shares
155
Price
$96.53
Total Value
$14.96K
Shares Held After
2,225,000
% of Holdings
0.0%

IRADIMED CORP (IRMD)

Susi Roger E. — Director
Mar 30, 2026
Sale
Shares
1,497
Price
$95.66
Total Value
$143.20K
Shares Held After
2,225,155
% of Holdings
0.1%

IRADIMED CORP (IRMD)

Susi Roger E. — Director
Mar 30, 2026
Sale
Shares
5,848
Price
$94.81
Total Value
$554.45K
Shares Held After
2,226,652
% of Holdings
0.3%
Mar 30, 2026
Purchase
Shares
445
Price
$112.30
Total Value
$49.97K
Shares Held After
187,616
% of Holdings
0.2%
Mar 30, 2026
Purchase
Shares
20,000
Price
$18.23
Total Value
$364.60K
Shares Held After
1,692,039
% of Holdings
1.2%
Mar 30, 2026
Sale
Shares
617
Price
$54.31
Total Value
$33.51K
Shares Held After
45,160
% of Holdings
1.3%
Mar 30, 2026
Sale
Shares
6,423
Price
$53.54
Total Value
$343.90K
Shares Held After
45,777
% of Holdings
12.3%
Mar 30, 2026
Sale
Shares
19,060
Price
$12.63
Total Value
$240.73K
Shares Held After
460,216
% of Holdings
4.0%
Mar 30, 2026
Purchase
Shares
10,000
Price
$2.85
Total Value
$28.50K
Shares Held After
414,462
% of Holdings
2.4%

PRECIGEN, INC. (PGEN)

KIRK RANDAL J — Director
Mar 30, 2026
Sale
Shares
2,334,420
Price
$3.30
Total Value
$7.70M
Shares Held After
12,262,741
% of Holdings
16.0%

PRECIGEN, INC. (PGEN)

KIRK RANDAL J — Director
Mar 30, 2026
Sale
Shares
23,789
Price
$3.30
Total Value
$78.50K
Shares Held After
423,984
% of Holdings
5.3%
Version: v26.3.33